CHI’s 5th Annual Immuno-Oncology Summit – Powering Next Generation Targeted Immunotherapies – saw record attendance! Over 550 delegates hailing from 26 countries gathered in Boston for a week-long summit of cutting-edge presentations by established Pharma & Biotech thought-leaders, top academics and researchers, and a collection of emerging scientists exploring next-generation breakthroughs in the burgeoning area of immuno-oncology. In addition to productive and energetic conference sessions, the exhibit hall also enjoyed record turnout, playing host to 36 exhibit booths and 39 poster presentations.
The Immuno-Oncology Summit At-A-Glance
Scientist/Technologist: 26%
Executive: 23%
Director: 20%
Manager: 6%
Sales/Marketing: 12%
Professor: 11%
Other: 2%
Biotech: 54%
Big Pharma: 17%
Academic: 11%
Healthcare Provider: 9%
Government/Finance/Press/Other: 7%
CRO: 2%
Mark Your Calendar!
The 6th Annual Immuno-Oncology Summit will be held August 27-31, 2018 at the Seaport World Trade Center in Boston, MA
The Immuno-Oncology Summit will return to Boston again this August 28-September 1 with the goal of supporting researchers in developing the next generation of immunotherapies. Immuno-oncology researchers are changing the way we treat cancer by unleashing the immune system and achieving functional cures in some cancers. This year's IO Summit has been designed to give attendees a complete picture of the field and its advances with 12 conference tracks, 1 in-depth training seminar, and 3 instructional short courses. Topics include immunotherapy discovery, development, biomarkers, and translational oncology as well as emerging topic areas such as cancer vaccines, oncolytic viruses, and advances in synthetic biology techniques. Overall, this event provides a focused look at how researchers are applying new science and technology in the development of effective and safe immunotherapies.
RECORD ATTENDANCE!
JOIN OVER 500 INTERNATIONAL IMMUNO-ONCOLOGY THOUGHT LEADERS!
View current list of pre-registered delegates!
Plenary Keynotes
Graeme E. Price, Ph.D.
Research Microbiologist,
Gene Transfer & Immunogenicity, FDA CBER
Gergana Zlateva, Ph.D.,
Vice President
Payer Insights and Access, Oncology, Pfizer
Learn more
Immuno-Oncology Summit Overview